… , abundant GM-CSF production at the sites of CNS inflammation suggests that GM-CSF …
reveal a potential mechanism of IFN-β therapy, namely suppression of GM-CSF production. …

… Multiple sclerosis (MS) is an inflammatory disease of the … patients in remission and on IFN-β
therapy were included in the … study already strongly suppressed the GM-CSF protein levels …

… GM-CSF may be a potential therapeutic target in MS. … Our finding of increased GM-CSF
expression in NK cells in … anti-IL-2 suppresses it and not only in Th cells but also other cell types. …

… slightly increased GM-CSF expression by γδ T cells and a … of T cells, and in particular of T
C cells, after 1 year of treatment. We … of MS without unspecific collateral immune suppression. …

… We show that IFN-β suppresses Th17 cells either directly or … DC were differentiated from
monocytes using GM-CSF and IL… IFN-β and IL-27 exerted similar effects on DC and T cell …

… IFN-β has been the treatment for multiple sclerosis (MS) for … patients have increased numbers
of GM-CSF + Th cells in … in GM-CSF expression by CD4 + T cells, total CD4 + T cells from …

… , abundant GM-CSF production at the sites of CNS inflammation suggests that GM-CSF …
reveal a potential mechanism of IFN-β therapy, namely suppression of GM-CSF production. …

… T cell proliferation is suppressed by the production of … The T cell population is decreased
after IFN-β treatment. AC: … , as F4/80 expression was significantly inhibited in the IFN-β treated …

… responses such as multiple sclerosis (MS) and … GM-CSF + CD4 + T cells are also frequent
in the lesions of untreated MS patients and that their numbers decrease after IFN-β treatment …

… effects on autoreactive T cells and promoting Th2 cells. It is … IFN-β synergistically suppressed
CD1a and enhanced CD86 … presence of GM-CSF and IL-4, with or without GA, or IFN-β, or …